Lincare Holdings Inc.  

(Public, NASDAQ:LNCR)   Watch this stock  
Find more results for LNCR
0.0000
- Close
NASDAQ real-time data - Disclaimer
Currency in
Range     -
52 week     -
Open     -
Vol. 0.00
Mkt cap 3.63B
P/E 0.00
Div/yield 0.20/∞T
EPS 2.10
Shares     -
Beta     -
Inst. own     -

Key stats and ratios

Q2 (Jun '12) 2011
Net profit margin 9.65% 9.60%
Operating margin 17.83% 17.76%
EBITD margin - 24.70%
Return on average assets 8.52% 8.51%
Return on average equity 21.53% 18.83%
Employees 10,841 -
CDP Score - -

Address

19387 U.S. 19 North
CLEARWATER, FL 33764
United States - Map
+1-727-5307700 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Lincare Holdings Inc. (Lincare) is a provider of oxygen, respiratory and other chronic therapy services to patients in the home. The Company�s customers suffer from chronic obstructive pulmonary disease (COPD), such as emphysema, chronic bronchitis or asthma, and require supplemental oxygen, respiratory and other chronic therapy services. As of December 31, 2011, the Company served more than 800,000 customers in 48 states of the United States and Canada through 1,108 operating centers. Lincare primarily provides oxygen, respiratory and other chronic therapy services to patients in the home. It also provides a variety of durable medical equipment (DME) and home infusion therapies in certain geographic markets. During the year ended December 31, 2011, the Company acquired companies that were contracted to provide home oxygen equipment and positive airway pressure devices. In August 2012, Lincare announced that The Linde Group completed its previously announced acquisition of the Company.